How can artificial intelligence (AI) be used to make bioprocessing more efficient? AI can help in a variety of ways, according to Michael Chen, PhD, CEO of Great Bay Bio, a Hong Kong-based company that applies AI to the development of biopharmaceuticals.
Science and Medicine Group Vice President of Digital Media Walt Schoenborn caught up with Chen at this week's meeting of the Society for Laboratory Automation and Screening (SLAS). Chen described how AI can be used to replace labor-intensive, expensive tasks that currently can slow down life sciences research.
Learn more in the video below: